We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Changes Generic Drug Policy to Accelerate Reviews
FDA Changes Generic Drug Policy to Accelerate Reviews
October 31, 2006
The FDA is changing its generic drug review policy, abandoning its “first come, first served” approach when there is a potential public health risk to ensure that these submissions are not delayed, the agency said.